Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Schedule Leading Up To Next Bard Hernia Mesh Bellwether Trial in Feb 2023 Outlined By Court The latest Bard hernia mesh lawsuit update for September 2022 outlines the pretrial deadlines leading up to the next bellwether trial that will begin on February 23, 2023, if settlements are not reached to resolve claims. September 19, 2022 Irvin Jackson Add Your Comments The U.S. District Judge presiding over thousands of hernia mesh lawsuits pending against C.R. Bard in the federal court system has released a pretrial schedule for various deadlines leading up to the next bellwether trial, which is set to go before a jury in February 2023. There are currently more than 17,500 product liability lawsuits pending in a Bard hernia mesh MDL (multidistrict litigation), which is centralized in the U.S. District Court for the Southern District of Ohio, including allegations that plaintiffs suffered painful complications due to design defects associated with certain polypropylene mesh products sold in recent years, including Bard Ventralex, Bard Ventralight, Bard Perfix, Bard 3DMax and other systems. As Bard hernia mesh products continue to fail and result in the need for additional surgery or treatment, the number of new lawsuits brought throughout the federal court system has more than doubled over the past year, rising from just over 8,000 claims pending in June 2021, and the size of the litigation is expected to continue to increase. Hernia Mesh Lawsuits Did you or a loved one receive a hernia mesh? Hernia mesh lawsuits are being filed against Bard, Atrium, Covidien and several other hernia mesh manufacturers over mesh failures resulting in injuries and additional surgery. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Hernia Mesh Lawsuits Did you or a loved one receive a hernia mesh? Hernia mesh lawsuits are being filed against Bard, Atrium, Covidien and several other hernia mesh manufacturers over mesh failures resulting in injuries and additional surgery. Learn More SEE IF YOU QUALIFY FOR COMPENSATION To help the parties gauge how juries are likely to respond to certain evidence and testimony that will be repeated throughout the litigation, a series of early “bellwether” trials have been scheduled in the federal court system, involving claims that are representative of other cases. While the outcomes of these early trial dates are not binding on other claims in the litigation, they are being closely watched by lawyers and parties involved, and may help drive hernia mesh settlements which would avoid the need for each individual case to go before a jury over the coming years. Third Bard Hernia Mesh Bellwether Trial Schedule Following two early trials with mixed results, with the manufacturer securing a defense verdict in the first trial in August 2021, and getting hit with a $255k verdict in a second trial that ended in April 2022, two additional cases are scheduled to go before juries next year. In a case management order (PDF) issued on September 9, the Court outlined various deadlines leading up to the start of the next Bard hernia mesh bellwether trial on February 21, 2023. According to the schedule, plaintiffs’ witness lists, Daubert motions, dispositive motions and other motions concerning expert witnesses are due by October 7, with opposition papers to those motions to be filed by November 4. Reply papers to dispositive motions are due by November 18. The defendants’ witness list is due by October 14. Motions in limine to challenge the admissibility of certain evidence at trial must be filed by December 2, with opposition responses due by December 16. All designations and objections to witnesses are to be submitted to the court no later than January 13, 2023. In addition, plaintiffs’ exhibit list is due by January 6, with the defendants’ exhibit list due by January 13. Parties will submit proposed jury instructions by January 27, and all unresolved objections must be submitted to the court by February 3. A pretrial conference will be held on February 9, followed by a second pretrial conference on February 10, with jury selection set to begin two weeks later. September 2022 Bard Hernia Mesh Lawsuit Update Following the next Bard hernia mesh bellwether trial in February 2023, a fourth case is currently scheduled to begin in May 2023. In addition to the federal lawsuits, Bard also faces thousands of similar hernia mesh lawsuits in coordinated litigation in Rhode Island state court, where the company has reached agreements to settle some cases. However, late last month a Rhode Island jury handed down a $4.8 million verdict for a plaintiff in the state court system, and Bard has suggested that it intends to challenge additional claims at trial. Following bellwether trials, if Bard hernia mesh settlements are not reached to resolve large numbers of claims, it is expected that the Court will start preparing large groups of cases for remand to U.S. District Courts nationwide next year. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: C. R. Bard, Hernia, Hernia Mesh, Ventralex, Ventralight More Hernia Mesh Lawsuit Stories Covidien Seeks Dismissal of Lawsuits Over Hernia Mesh Complications September 8, 2025 Deadline for Covidien Mesh Settlement Negotiations Extended Until Jan. 2026 August 21, 2025 LifeCell Seeks Dismissal of Strattice Hernia Mesh Lawsuit Set for Trial August 11, 2025 1 Comments Deborah October 31, 2022 They are no longer wanting to settle. URLThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Ozempic Gastroparesis Problems Persisted After Injections Stopped, Lawsuit Alleges (Posted: today) A lawsuit claims that a man’s Ozempic gastroparesis side effects have continued a year and a half after he stopped using the diabetes medication. MORE ABOUT: OZEMPIC LAWSUITOzempic, Wegovy Kidney Side Effects Highlighted in New Study (10/10/2025)Lawsuits Over Vision Loss From Ozempic, Mounjaro Should Be Sent to New MDL Judge, Plaintiffs Argue (10/07/2025)Reports of ‘Ozempic Teeth’ Raise Concerns Over Dry Mouth Side Effects Linked to GLP-1s (10/03/2025) Depo-Provera Side Effects Hidden for Decades, Lawsuit Alleges (Posted: yesterday) A woman’s Depo-Provera lawsuit says the manufacturers’ failure to warn doctors and patients of the risk of intracranial meningioma led to her developing two brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITOver 1,300 Depo Shot Lawsuits Now Being Pursued by Women With Meningioma Tumors (10/06/2025)Depo-Provera Brain Tumor Lawsuit Describes Left-Sided Numbness, Tingling Before Diagnosis (10/01/2025)Judge To Hear Depo-Provera Lawsuit Preemption Arguments on Monday (09/26/2025) Dupixent Lawyers To Meet With Court for Initial Conference in T-Cell Lymphoma Lawsuit (Posted: 4 days ago) Parties involved in a Dupixent T-cell lymphoma wrongful death lawsuit will participate in an initial status conference in early December, to map out how the litigation will move forward. MORE ABOUT: DUPIXENT LAWSUITDupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (10/08/2025)Dupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025)
Ozempic Gastroparesis Problems Persisted After Injections Stopped, Lawsuit Alleges (Posted: today) A lawsuit claims that a man’s Ozempic gastroparesis side effects have continued a year and a half after he stopped using the diabetes medication. MORE ABOUT: OZEMPIC LAWSUITOzempic, Wegovy Kidney Side Effects Highlighted in New Study (10/10/2025)Lawsuits Over Vision Loss From Ozempic, Mounjaro Should Be Sent to New MDL Judge, Plaintiffs Argue (10/07/2025)Reports of ‘Ozempic Teeth’ Raise Concerns Over Dry Mouth Side Effects Linked to GLP-1s (10/03/2025)
Depo-Provera Side Effects Hidden for Decades, Lawsuit Alleges (Posted: yesterday) A woman’s Depo-Provera lawsuit says the manufacturers’ failure to warn doctors and patients of the risk of intracranial meningioma led to her developing two brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITOver 1,300 Depo Shot Lawsuits Now Being Pursued by Women With Meningioma Tumors (10/06/2025)Depo-Provera Brain Tumor Lawsuit Describes Left-Sided Numbness, Tingling Before Diagnosis (10/01/2025)Judge To Hear Depo-Provera Lawsuit Preemption Arguments on Monday (09/26/2025)
Dupixent Lawyers To Meet With Court for Initial Conference in T-Cell Lymphoma Lawsuit (Posted: 4 days ago) Parties involved in a Dupixent T-cell lymphoma wrongful death lawsuit will participate in an initial status conference in early December, to map out how the litigation will move forward. MORE ABOUT: DUPIXENT LAWSUITDupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (10/08/2025)Dupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025)